Technical Specifications

• CAS Number: 2381089-83-2
• Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
• Molecular Weight: 4845.44 g/mol
• PubChem ID: 474492335
• Purity: ≥99% (HPLC tested)
• Form: Lyophilized powder
• Synthesis Method: Solid-phase peptide synthesis

Analytical & Testing

Each batch of Retatrutide (Reta) undergoes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) analysis to verify purity, identity, and analytical consistency. A corresponding Certificate of Analysis (COA) is available for each batch.

Handling & Storage

This compound should be handled by qualified professionals in controlled laboratory environments. Proper storage conditions should be maintained to preserve compound stability and structural integrity.

Research Context

In preclinical and laboratory research models, Retatrutide has been examined across metabolic, endocrine, and systemic research systems. Research focus includes:

• GLP-1 receptor signaling pathways
• GIP receptor activity models
• Glucagon receptor interactions
• Multi-hormone signaling mechanisms

These observations are limited to controlled experimental environments and support ongoing laboratory investigations.

Research Application Scope

Retatrutide (Reta) continues to be evaluated for its relevance in experimental biology, particularly within studies involving multi-receptor signaling, metabolic pathway analysis, and integrated biochemical interactions.

Use Statement

For laboratory research use only. Intended strictly for in vitro research applications.

Disclaimer

All products currently listed on this site are for research purposes ONLY.